Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Fiziol Zh (1994) ; 61(5): 35-45, 2015.
Artigo em Ucraniano | MEDLINE | ID: mdl-26845842

RESUMO

The adult rats received both neurotoxin 6-hidroxidophamine and neurotoxin and melatonin. It was investigated a link between the disturbances of the brain antioxidant enzymes activity and thymic endocrine function, as possible pathogenic factors of parkinsonism, with changes in the number of neural stem cells (NSC) in the bulbus olfactorius. Rats with motor asymmetry in the apomorphine test and significant damage of the dopaminergic neurons in the-substantia nigra have decreased levels of superoxide dismutase, catalase and glutathione peroxidase activities in striatum (1.3-1.4 times) and blood thymulin content (8 times) compared to control group. On the contrary, examined indices were not changed in rats without motor asymmetry and correspondingly partly damaged neurons. The number of nestin(+)-cells in the bulbus olfactorius of rats without motor asymmetry increased from 91.2% to 99.3% and remained unchanged after melatonin administration course (10 mg/kg during 18 days). Melatonin administration resulted in the decrease in the number of nestin(+)-cells along with significant elevation of the decreased antioxidant enzymes activity and blood thymulin content in rats with circulatory movements. Possibilities of the enhancement of NSC differentiation in bulbus olfactorius into neuronal direction in such animals has been discussed. The conclusion about the potential use of melatonin as a neuroprotector in parkinsonism therapy has been made.


Assuntos
Antioxidantes/farmacologia , Ataxia/prevenção & controle , Melatonina/farmacologia , Fármacos Neuroprotetores/farmacologia , Bulbo Olfatório/efeitos dos fármacos , Doença de Parkinson Secundária/tratamento farmacológico , Timo/efeitos dos fármacos , Animais , Apomorfina/antagonistas & inibidores , Apomorfina/farmacologia , Ataxia/induzido quimicamente , Ataxia/genética , Ataxia/patologia , Catalase/genética , Catalase/metabolismo , Contagem de Células , Diferenciação Celular/efeitos dos fármacos , Agonistas de Dopamina/farmacologia , Expressão Gênica , Glutationa Peroxidase/genética , Glutationa Peroxidase/metabolismo , Masculino , Nestina/genética , Nestina/metabolismo , Células-Tronco Neurais/citologia , Células-Tronco Neurais/efeitos dos fármacos , Células-Tronco Neurais/metabolismo , Bulbo Olfatório/metabolismo , Bulbo Olfatório/patologia , Oxidopamina , Doença de Parkinson Secundária/induzido quimicamente , Doença de Parkinson Secundária/genética , Doença de Parkinson Secundária/patologia , Ratos , Ratos Wistar , Superóxido Dismutase/genética , Superóxido Dismutase/metabolismo , Fator Tímico Circulante/genética , Fator Tímico Circulante/metabolismo , Timo/metabolismo , Timo/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...